Trafalgar International, Inc. (GCAND)
OTCMKTS · Delayed Price · Currency is USD
1.600
+0.020 (1.27%)
At close: Sep 22, 2026
Trafalgar International Company Description
Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors.
The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026.
The company was founded in 2014 and is based in Miami, Florida.
Trafalgar International, Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Carlos Septien Michel |
Contact Details
Address: 200 South Biscayne Blvd Miami, Florida 33131 United States | |
| Phone | 443 738 4051 |
| Website | gcanrx.com |
Stock Details
| Ticker Symbol | GCAND |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Porfirio Sanchez-Talavera | Chief Executive Officer and Chairman of the Board |
| Michelle Cervantes Vivanco | Chief Financial Officer and Director |
| Carlos Septien Michel | Chief Operating Officer and Director |
| Ernesto Gomez Berjon | Chief Growth Officer and Director |